F
54
-6
VTR
55
-3
PSX
42
-3
MU
52
-3
FITB
58
-2
WBA
37
3
PEG
48
-5
PAYX
57
6
CMA
50
-6
ETR
65
2
CF
48
4
DAL
33
-2
GPC
50
2
NWS
69
-2
SE
75
3
WAT
47
4
AAL
21
-3
USB
48
-3
VIX
43
5
PG
68
5
F
54
-6
VTR
55
-3
PSX
42
-3
MU
52
-3
FITB
58
-2
WBA
37
3
PEG
48
-5
PAYX
57
6
CMA
50
-6
ETR
65
2
CF
48
4
DAL
33
-2
GPC
50
2
NWS
69
-2
SE
75
3
WAT
47
4
AAL
21
-3
USB
48
-3
VIX
43
5
PG
68
5
Financhill
Back

Recruit Holdings Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
25

RCRUY
Recruit Holdings

Last Price:
$10.35
Seasonality Move:
11.81%
Buy
53

SRPT
Sarepta Therapeutics

Last Price:
$70.37
Seasonality Move:
17.94%
Sell
25
Recruit Holdings (RCRUY) is a Sell

Is Recruit Holdings a Buy, Sell or Hold?

  • The current Recruit Holdings [RCRUY] share price is $10.83. The Score for RCRUY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • RCRUY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $71.81. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RCRUY Stock Price Chart

What is Recruit Holdings's stock price today?

  • The Recruit Holdings share price today is $10.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCRUY is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $71.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

RCRUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 31.61 Sell
Chaikin Money Flow: -140186 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.02 - 12.52) Sell
Bollinger Bands (100): (12.03 - 14.37) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.92 Sell
Relative Strength Index (14 RSI): 28.2 Sell
Chaikin Money Flow: -798774 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.35 - 108.37) Sell
Bollinger Bands (100): (98.9 - 127.68) Sell

RCRUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.89 Sell
20-day SMA: 11.54 Sell
50-day SMA: 12.8 Sell
200-day SMA: 12.41 Sell
8-day EMA: 11 Sell
20-day EMA: 11.53 Sell
50-day EMA: 12.39 Sell
200-day EMA: 12.09 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 74.46 Sell
20-day SMA: 91.18 Sell
50-day SMA: 104.46 Sell
200-day SMA: 124.15 Sell
8-day EMA: 77.38 Sell
20-day EMA: 87.73 Sell
50-day EMA: 100.49 Sell
200-day EMA: 116.63 Sell

Recruit Holdings Earnings Growth & RCRUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Recruit Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):